PRESS RELEASE published on 08/13/2025 at 16:03, 3 months 22 days ago INTRASENSE : DUOnco™ Pancreas CE marking: a key innovation for the early detection of pancreactic cancer using AI Intrasense obtains CE marking under MDR for DUOnco™ Pancreas, an AI solution enhancing early detection of pancreatic cancer. CEO Alexandre Salvador highlights the innovation's importance in clinical practice and patient care AI Pancreatic Cancer CE Marking Intrasense DUOnco Pancreas
BRIEF published on 08/13/2025 at 15:59, 3 months 22 days ago Intrasense Obtains CE Certification for DUOnco™ Pancreas, a Breakthrough in Oncology Artificial Intelligence Oncology CE Certification Intrasense DUOnco™ Pancreas
BRIEF published on 07/28/2025 at 10:40, 4 months 7 days ago Half-Yearly Review of the Intrasense Liquidity Contract Liquidity Contract Actions Stock Market Transactions FASD Intrasense
BRIEF published on 06/06/2025 at 15:12, 5 months 28 days ago Intrasense Expands AI Solutions in Oncological Imaging Intrasense AI Imaging Oncology Solutions Myrian® DUOnco™
PRESS RELEASE published on 06/06/2025 at 15:07, 5 months 28 days ago Activity Update: structured offering of AI Solutions in oncological imaging and initial successful deployments Intrasense provides structured AI solutions for oncological imaging, incl. Myrian®, DUOnco™, and Liflow®. Successful deployments & collaborations enhance patient care AI Solutions Medical Imaging Collaborations Intrasense Oncological Imaging
BRIEF published on 05/23/2025 at 19:22, 6 months 12 days ago Intrasense Announces Board of Directors Change Board Of Directors Medical Imaging AI In Healthcare Intrasense Steven F. Tolle
PRESS RELEASE published on 05/23/2025 at 19:17, 6 months 12 days ago Annule et remplace : Change in the Composition of the Intrasense Board of Directors Intrasense announces a change in its Board of Directors with the resignation of Mrs. Michèle Lesieur and co-opting Mr. Steven F. Tolle. Mr. Tolle brings extensive healthcare experience Board Of Directors Resignation Healthcare Experience Intrasense Steven F. Tolle
BRIEF published on 09/09/2024 at 17:56, 1 year 2 months ago Intrasense announces its participation in the 2024 Francophone Radiology Days Innovation Synergies Radiology Intrasense JFR 2024
BRIEF published on 07/25/2024 at 17:58, 1 year 4 months ago Intrasense announces its 2024 half-year turnover Software Solutions Reorganization Turnover Intrasense Geopolitics
BRIEF published on 06/10/2024 at 07:56, 1 year 5 months ago Ordinary annual and extraordinary General Meeting of June 25, 2024: provision of preparatory documents and terms of participation Shareholders General Assembly Preparatory Documents Voting Conditions Intrasense
Published on 12/05/2025 at 02:35, 1 hour 55 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 30 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 25 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 30 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 59 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 39 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 4 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 15 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 19 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 45 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 46 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 29 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
